3-Aminoquinazolinediones as a New Class of Antibacterial Agents Demonstrating Excellent Antibacterial Activity Against Wild-Type and Multidrug Resistant Organisms
- 4 October 2006
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (22) , 6435-6438
Abstract
The 3-aminoquinzolinediones represent a new series of antibacterial agents structurally related to the fluoroquinolones. They are inhibitors of bacterial gyrase and topoisomerase IV and demonstrate clinically useful antibacterial activity against fastidious Gram-negative and Gram-positive organisms, including multidrug- and fluoroquinolone-resistant organisms. These agents also demonstrate in vivo efficacy in murine systemic infection models.Keywords
This publication has 15 references indexed in Scilit:
- Glycopeptide and Lipoglycopeptide AntibioticsChemical Reviews, 2005
- In Vitro Antibacterial Activity and Pharmacodynamics of New QuinolonesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- Bacterial Resistance: Origins, Epidemiology, and ImpactClinical Infectious Diseases, 2003
- Dual Targeting of DNA Gyrase and Topoisomerase IV: Target Interactions of Garenoxacin (BMS-284756, T-3811ME), a New DesfluoroquinoloneAntimicrobial Agents and Chemotherapy, 2002
- Emerging Mechanisms of Fluoroquinolone ResistanceEmerging Infectious Diseases, 2001
- Mechanisms of Fluoroquinolone Resistance: An Update 1994-1998Drugs, 1999
- DNA Cleavage Is Not Required for the Binding of Quinolone Drugs to the DNA Gyrase−DNA ComplexBiochemistry, 1996
- Quinolone Mode of Action - New Aspects†Drugs, 1993
- beta-Lactamase stability and in vitro activity of oral cephalosporins against strains possessing well-characterized mechanisms of resistanceAntimicrobial Agents and Chemotherapy, 1989
- New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assayJournal of Medicinal Chemistry, 1986